Chapter 1. Oncolytic Virus Diagnostics Market – Scope & Methodology
1.1 Market Segmentation
1.2 Scope, Assumptions & Limitations
1.3 Research Methodology
1.4 Primary Sources
1.5 Secondary Sources
Chapter 2. Oncolytic Virus Diagnostics Market – Executive Summary
2.1 Market Size & Forecast – (2024 – 2030) ($M/$Bn)
2.2 Key Trends & Insights
2.2.1 Demand Side
2.2.2 Supply Side
2.3 Attractive Investment Propositions
2.4 COVID-19 Impact Analysis
Chapter 3. Oncolytic Virus Diagnostics Market – Competition Scenario
3.1 Market Share Analysis & Company Benchmarking
3.2 Competitive Strategy & Development Scenario
3.3 Competitive Pricing Analysis
3.4 Supplier-Distributor Analysis
Chapter 4. Oncolytic Virus Diagnostics Market - Entry Scenario
4.1 Regulatory Scenario
4.2 Case Studies – Key Start-ups
4.3 Customer Analysis
4.4 PESTLE Analysis
4.5 Porters Five Force Model
4.5.1 Bargaining Power of Suppliers
4.5.2 Bargaining Powers of Customers
4.5.3 Threat of New Entrants
4.5.4 Rivalry among Existing Players
4.5.5 Threat of Substitutes
Chapter 5. Oncolytic Virus Diagnostics Market – Landscape
5.1 Value Chain Analysis – Key Stakeholders Impact Analysis
5.2 Market Drivers
5.3 Market Restraints/Challenges
5.4 Market Opportunities
Chapter 6. Oncolytic Virus Diagnostics Market – By Therapy Type
6.1 Introduction/Key Findings
6.2 HSV-based
6.3 Adenovirus-based
6.4 Reovirus
6.5 Poxviruses
6.6 NDV
6.7 Others
6.8 Y-O-Y Growth trend Analysis By Therapy Type
6.9 Absolute $ Opportunity Analysis By Therapy Type, 2024-2030
Chapter 7. Oncolytic Virus Diagnostics Market – By Indication
7.1 Introduction/Key Findings
7.2 Head & Neck
7.3 Lung
7.4 Kidney
7.5 Liver
7.6 Pancreatic
7.7 Breast
7.8 Colorectal
7.9 Sarcoma
7.10 Melanoma
7.11 Y-O-Y Growth trend Analysis By Indication
7.12 Absolute $ Opportunity Analysis By Indication, 2024-2030
Chapter 8. Oncolytic Virus Diagnostics Market , By Geography – Market Size, Forecast, Trends & Insights
8.1 North America
8.1.1 By Country
8.1.1.1 U.S.A.
8.1.1.2 Canada
8.1.1.3 Mexico
8.1.2 By Therapy Type
8.1.3 By Indication
8.1.4 Countries & Segments - Market Attractiveness Analysis
8.2 Europe
8.2.1 By Country
8.2.1.1 U.K
8.2.1.2 Germany
8.2.1.3 France
8.2.1.4 Italy
8.2.1.5 Spain
8.2.1.6 Rest of Europe
8.2.2 By Therapy Type
8.2.3 By Indication
8.2.4 Countries & Segments - Market Attractiveness Analysis
8.3 Asia Pacific
8.3.1 By Country
8.3.1.1 China
8.3.1.2 Japan
8.3.1.3 South Korea
8.3.1.4 India
8.3.1.5 Australia & New Zealand
8.3.1.6 Rest of Asia-Pacific
8.3.2 By Therapy Type
8.3.3 By Indication
8.3.4 Countries & Segments - Market Attractiveness Analysis
8.4 South America
8.4.1 By Country
8.4.1.1 Brazil
8.4.1.2 Argentina
8.4.1.3 Colombia
8.4.1.4 Chile
8.4.1.5 Rest of South America
8.4.2 By Therapy Type
8.4.3 By Indication
8.4.4 Countries & Segments - Market Attractiveness Analysis
8.5 Middle East & Africa
8.5.1 By Country
8.5.1.1 United Arab Emirates (UAE)
8.5.1.2 Saudi Arabia
8.5.1.3 Qatar
8.5.1.4 Israel
8.5.1.5 South Africa
8.5.1.6 Nigeria
8.5.1.7 Kenya
8.5.1.8 Egypt
8.5.1.9 Rest of MEA
8.5.2 By Therapy Type
8.5.3 By Indication
8.5.4 Countries & Segments - Market Attractiveness Analysis
Chapter 9. Oncolytic Virus Diagnostics Market – Company Profiles – (Overview, Product Portfolio, Financials, Strategies & Developments)
9.1 Amgen Inc.
9.2 Shanghai Sunway Biotech Co. Ltd.
9.3 Oncolys BioPharma Inc.
9.4 TILT Biotherapeutics Ltd.
9.5 Oncorus Inc.
9.6 TAKARA BIO INC.
9.7 Vyriad
9.8 Transgene SA
9.9 Lokon Pharma AB
9.10 Pfizer Inc.
2500
4250
5250
6900
Frequently Asked Questions
The Global Oncolytic Virus Diagnostics Market was valued at USD 0.22 billion in 2023 and is projected to reach a market size of USD 1.17 billion by the end of 2030. Over the forecast period of 2024-2030, the market is projected to grow at a CAGR of 27%.
Advancements in diagnostic technologies and a growing focus on personalized cancer therapies are key drivers for the Global Oncolytic Virus Diagnostics Market.
The segments under the Global Oncolytic Virus Diagnostics Market By End Users include Hospitals, Diagnostic Centers, and Research Institutes..
North America is the most dominant region for the Global Oncolytic Virus Diagnostics Market.
The leading players in the Global Oncolytic Virus Diagnostics Market include Thermo Fisher Scientific, Abbott Laboratories, Siemens Healthineers, and Bio-Rad Laboratories.